Holen Sie sich die Stockscreener-App
47.37
0.00%
0.00
Handel nachbörslich:
47.47
0.10
+0.21%
Schlusskurs vom Vortag:
$47.37
Offen:
$46.9
24-Stunden-Volumen:
26,553
Relative Volume:
0.48
Marktkapitalisierung:
$229.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.01%
1M Leistung:
+1.87%
6M Leistung:
+23.84%
1J Leistung:
+3.56%
1-Tages-Spanne:
$46.90
$47.68
1-Wochen-Bereich:
$46.90
$48.84
52-Wochen-Spanne:
$35.22
$49.31
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Firmenname
Spdr Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
47.37 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
326.88 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
662.20 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
665.46 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
255.56 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
598.00 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Aktie (XPH) Neueste Nachrichten
XPH: Small-Cap Pharma Turns Higher, At Long Last (NYSEARCA:XPH) - Seeking Alpha
Seeking Alpha's healthcare quant picks ahead of Q3 earnings: McKesson, Incyte top-rated stocks - MSN
P Pharmaceuticals ETF stock beat international competitionJuly 2025 Big Picture & Weekly Top Gainers Alerts - newser.com
Short bets on S&P 500 Healthcare sector rises marginally to 1.91% in September; MRNA remains most shorted stock - Seeking Alpha
P Pharmaceuticals ETF stock protected from inflationJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - sharewise.com
INCY and ABBV lead S&P 500 healthcare gainers in Q3; MOH and ALGN lag - MSN
Pharma stocks at 15-year valuation lows may offer value – BMO’s Evan Seigerman - Seeking Alpha
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
P Pharmaceuticals ETF stock return to pre crash levelsWatch List & Safe Entry Point Identification - newser.com
6 Best Health Care Funds and ETFs for 2025 - US News Money
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - inkl
P Pharmaceuticals ETF stock prepared for digital transitionTrade Analysis Summary & Capital Efficiency Focused Strategies - newser.com
Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff - inkl
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - Yahoo Finance
SPDR S&P Biotech ETF (XBI) Top 25 Holdings - TIKR.com
SPDR S&P Pharmaceuticals ETF $XPH Stake Boosted by Goldman Sachs Group Inc. - Defense World
Short bets on S&P 500 Healthcare sector eases in August; MRNA stays most shorted stock - Seeking Alpha
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
The Best Health Care ETFs to Buy - Kiplinger
XLV Vs. IHE: Will Pharmaceuticals Outperform Healthcare? (NYSEARCA:XLV) - Seeking Alpha
Simplex Trading LLC Buys Shares of 627 SPDR S&P Pharmaceuticals ETF $XPH - Defense World
Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy. - inkl
SPDR S&P Pharmaceuticals ETF $XPH Stock Position Reduced by Cetera Investment Advisers - Defense World
PJP: Healthcare Dashboard For August (NYSEARCA:PJP) - Seeking Alpha
Short bets on S&P 500 Healthcare sector ease in July; Moderna remains most heavily shorted stock - MSN
Market Voices: Bessent clarifies Fed comments, pharma tariffs, Target - Seeking Alpha
Blair William & Co. IL Buys Shares of 686 SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)? - Yahoo Finance
Blair William & Co. IL Purchases 251 Shares of Vanguard S&P Mid-Cap 400 ETF (NYSEARCA:IVOO) - Defense World
XTX Topco Ltd Invests $204,000 in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
LPL Financial LLC Decreases Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Cetera Investment Advisers Increases Holdings in SPDR S&P Fossil Fuel Reserves Free ETF (NYSEARCA:SPYX) - Defense World
7 Best Biotech ETFs to Buy Now - US News Money
Investors Purchase High Volume of Call Options on SPDR S&P Regional Banking ETF (NYSEARCA:KRE) - Defense World
4. SPDR S&P Pharmaceuticals ETF (ARCA:XPH) - Investing News Network
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Finanzdaten der Spdr Pharmaceuticals Etf-Aktie (XPH)
Es liegen keine Finanzdaten für Spdr Pharmaceuticals Etf (XPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.85%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):